We are live on ! Find out more
ECP

Empyrean Capital Partners Portfolio holdings

AUM $3.03B
1-Year Est. Return 47.81%
This Fund
S&P 500
This Quarter Est. Return
+18.67%
1 Year Est. Return
+47.81%
3 Year Est. Return
+131.37%
5 Year Est. Return
+161.39%
10 Year Est. Return
+590.42%
AUM
$3.16B
AUM Growth
+$1.29B
Cap. Flow
-$113M
Cap. Flow %
-3.6%
Top 10 Hldgs %
54.05%
Holding
89
New
25
Increased
13
Reduced
14
Closed
10

Sector Composition

Rank Sector Weight
1 Miscellaneous 47.49%
2 Financials 14.66%
3 Communication Services 10.59%
4 Technology 8.15%
5 Healthcare 6.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HRG
76
DELISTED
HRG Group, Inc.
HRG
-5,602,112
Closed -$92.4M

Similar funds

Empyrean Capital Partners's Q2 2018 Portfolio in Review

As of Q2 2018, Empyrean Capital Partners held 89 positions worth $3.16B, up 69% from $1.87B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Empyrean Capital Partners withdrew a net $113M in Q2 2018, closing 10 positions and reducing 14 holdings. Its most notable exit was Time Warner Inc, an estimated $182M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, up from 26% a quarter earlier, followed by Financials and Communication Services.

Against the trend, Empyrean Capital Partners opened a new position in Aetna Inc worth $139M.

  • Empyrean Capital Partners's largest Q2 2018 buy was Aetna Inc: 759,600 shares worth $139M.
  • Empyrean Capital Partners added most to NXP Semiconductors in Q2 2018, an estimated $31.1M increase.
  • Empyrean Capital Partners's biggest Q2 2018 reduction was Pfizer, cutting an estimated $33.3M.
  • Empyrean Capital Partners fully exited Time Warner Inc in Q2 2018, selling an estimated $182M.
  • Empyrean Capital Partners's ten largest holdings make up 54% of its $3.16B portfolio in Q2 2018.
  • Empyrean Capital Partners opened 25 new positions and closed 10 in Q2 2018.
  • Empyrean Capital Partners's portfolio value rose 69% quarter-over-quarter to $3.16B.

Based on Empyrean Capital Partners's 13F filing for Q2 2018, filed 14 Aug 2018.